期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

系统性红斑狼疮合并疑似抗磷脂抗体综合征1例

下载PDF
导出
摘要 系统性红斑狼疮（SLE）是一种有多系统损害的慢性自身免疫性疾病，约有20％的患者可合并抗磷脂抗体综合征（APS），表现为血小板减少和血栓形成等，现将我科收治的系统性红斑狼疮合并疑似抗磷脂抗体综合征1例报道如下。
作者 陈梅花 周飞红 曾宪玉 张平
机构地区 武汉市第一医院皮肤科
出处 《中国麻风皮肤病杂志》 2012年第1期49-50,共2页 China Journal of Leprosy and Skin Diseases
关键词 抗磷脂抗体综合征 系统性红斑狼疮 疑似 慢性自身免疫性疾病 多系统损害 血小板减少 血栓形成
分类号 R593.241 [医药卫生—内科学]
  • 相关文献

参考文献9

  • 1Hughes GRV.The anticardiolipin syndrome.Clin Exp Rheumatol 1983;3:285.
  • 2Harris EN,Gharavi AE,Hughes GRV.Antiphospho-lipid antibodoes.Clin Rheum Dis 1985;11:591.
  • 3鲍春德,陈晓翔.抗磷脂综合征诊治进展[J].医师进修杂志,2004,27(12):4-7. 被引量：16
  • 4Cervera R,Piette JC,Font J,et al.Antiphospholipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Arthritis Rheum 2002;46:1019-1027.
  • 5Weinstein S,Piette W.Cutaneous manifestations of antiphospholipid antibody syndrome.Hematol Oncol Clin North Am 2008;22:67-77.
  • 6Diogenes MJ,Diogenes PC,de Morais Carneiro RM,et al.Cutaneous manifestations associated with antiphospholipid antibodies.Int J Dermatol 2004;43:632-637.
  • 7Toubi E,Krause I,Fraser A,et al.Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome.Clin Exp Rheumatol 2005;23:499-504.
  • 8Erkan D,Lockshin MD.New approaches for managing antiphospholipidsyndrome.Nat Clin Pract Rheumatol 2009;5:160-170.
  • 9Crowther MA,Ginsberg JS,Julian J,et al.A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.N Engl J Med 2003;349:1133-1138.

二级参考文献11

  • 1MATSUURA E, KOBAYASHI K, KOIKE T, et al. Autoantibody-mediated atherosclerosis[J]. Autoimmunity Reviews, 2002,1:348.
  • 2ERKAN D,MERRILL J T,YAZICI Y,et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin[J]. Arthritis Rheum,2001,44:1 466-1 467.
  • 3AMENGUAL O,ATSUMI T,KHAMASHTA M A. Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium[J]. Rheumatology (Oxford),2003,42(9):1 029-1 031.
  • 4ESPINOSA G,CERVERA R,FONT J,et al. Antiphospholipid syndrome: pathogenic mechanisms[J].Autoimmun Rev,2003,2(2):86-93.
  • 5MOLL S,ORTEL T L. Monitoring warfarin therapy in patients with lupus anticoagulants[J].Ann Intern Med,1997,127:177-185.
  • 6LE D T,WEIBERT R T,SEVILLA B K,et al. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods[J]. Ann Intern Med,1994,120:552-558.
  • 7BRANCH D W,KHAMASHTA M A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies[J]. Obstet Gynecol,2003,101:1 333-1 344.
  • 8LIND S E,CALLAS P W,GOLDEN E A,et al. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy[J]. Blood Coagulation Fibrinoloysis,1997,8:48-53.
  • 9FERRARA D E,LIU X W,ESPINOLA R G,et al. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model[J]. Arthritis Rheumatism,2003,40(11):3 272-3 279.
  • 10TRIOLO G,FERRANTE A,CICCIA F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies[J].Arthritis Rheum,2003,

共引文献15

中国麻风皮肤病杂志
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部